Home
About
Overview
Sharing Data
ORCID
Help
History (1)
PDI inhibitor LTI6426 enhances panobinostat efficacy in preclinical models of multiple myeloma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
PDI inhibitor LTI6426 enhances panobinostat efficacy in preclinical models of multiple myeloma.
PDI inhibitor LTI6426 enhances panobinostat efficacy in preclinical models of multiple myeloma. Cancer Chemother Pharmacol. 2022 05; 89(5):643-653.
View in:
PubMed
subject areas
Animals
Histone Deacetylase Inhibitors
HSP40 Heat-Shock Proteins
Humans
Hydroxamic Acids
Mice
Molecular Targeted Therapy
Multiple Myeloma
Protein Disulfide-Isomerases
authors with profiles
Nathan Graeme Dolloff
Reeder M. Robinson